Showing results (931-940 of 1,243) with videos related to

Sort By:
Pageof 125
Nature Medicine|March 30, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiencyStefan D Anker, Mahir Karakas, Robert J Mentz, et al.
European Journal of Heart Failure|December 22, 2017
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HFSean D Pokorney, Sana M Al-Khatib, Jie-Lena Sun, et al.
ESC Heart Failure|June 1, 2021
Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failureAbhinav Sharma, Stephen Greene, Muthiah Vaduganathan, et al.
Journal of the American Heart Association|December 8, 2020
Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HFMarat Fudim, Jeremy Brooksbank, Anna Giczewska, et al.
BMJ Open|September 6, 2024
Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trialHector J Nuñez-Medina, Mariangeli Monero, Lorna M Torres, et al.
Nutrients|September 28, 2024
Evaluation of Polyphenol Intake in Pregnant Women from South-Eastern Spain and the Effect on Anthropometric Measures at Birth and Gestational AgeDaniel Hinojosa-Nogueira, Desirée Romero-Molina, Beatriz González-Alzaga, et al.
The Breast Journal|March 29, 2019
Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based modelPrashant Gabani, Ashley A Weiner, Leonel F Hernandez-Aya, et al.
Circulation|June 4, 2024
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart AssociationKaren E Joynt Maddox, Mitchell S V Elkind, Hugo J Aparicio, et al.
ESC Heart Failure|May 1, 2021
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fractionMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
JAMA|June 4, 2014
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%Sana M Al-Khatib, Anne S Hellkamp, Gregg C Fonarow, et al.
Pageof 125